India’s private sector needs to take greater role in tuberculosis careBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4774 (Published 02 September 2016) Cite this as: BMJ 2016;354:i4774
- Sanjeet Bagcchi
India’s private medical sector needs to get more involved in the management and control of tuberculosis, researchers reporting in two new studies in Lancet Infectious Diseases have said.1 2
The first study, led by Nimalan Arinaminpathy, senior lecturer at the Department of Infectious Disease Epidemiology, Imperial College London, considered the sales of 189 antituberculosis drugs in India during 2013-14 to calculate the number of patients who were treated in the private sector in that period. It estimated that the number of cases of tuberculosis treated in the private sector in 2014 was 2.2 million, more than double the currently estimated number …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial